Adma Biologics, Inc. (adma) Shareholders... - Jun 23

The Story

The Law Offices of Howard G. Smith announced on Jun 23, 2026 that investors who suffered substantial losses may have the opportunity to lead a securities fraud class action against ADMA Biologics, Inc. (NASDAQ: ADMA, $ADMA). The firm is inviting affected investors to contact them about lead-plaintiff status in the proposed lawsuit.

Why It Matters For Your Portfolio

• Announcement Date: Jun 23, 2026, placing the notice squarely during today’s market session and likely increasing near-term attention on $ADMA.
• One law firm, The Law Offices of Howard G. Smith, is publicly soliciting investors, which often precedes formal filings and consolidated complaints that can drive volatility.
• The release did not include specific share-price moves or loss amounts, so current $ADMA price action and realized losses for shareholders are unknown; check live quotes for exact figures before acting.
• Litigation risk can increase potential downside and add legal costs or settlement uncertainty, which could pressure shareholder value until resolved.

The Trade

Who should care? Current and former $ADMA shareholders with losses, and active traders watching volatility, should take note. Analysts and counsel will watch for formal court filings and lead-plaintiff motions as the next catalysts. Monitor firm announcements and SEC or court filings for specific deadlines and details, since the press release did not provide timelines.